AtriCure Long Term Debt vs Total Stockholder Equity Analysis

ATRC Stock  USD 35.68  0.35  0.97%   
AtriCure financial indicator trend analysis is way more than just evaluating AtriCure prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether AtriCure is a good investment. Please check the relationship between AtriCure Long Term Debt and its Total Stockholder Equity accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AtriCure. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
For information on how to trade AtriCure Stock refer to our How to Trade AtriCure Stock guide.

Long Term Debt vs Total Stockholder Equity

Long Term Debt vs Total Stockholder Equity Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of AtriCure Long Term Debt account and Total Stockholder Equity. At this time, the significance of the direction appears to have almost identical trend.
The correlation between AtriCure's Long Term Debt and Total Stockholder Equity is 0.93. Overlapping area represents the amount of variation of Long Term Debt that can explain the historical movement of Total Stockholder Equity in the same time period over historical financial statements of AtriCure, assuming nothing else is changed. The correlation between historical values of AtriCure's Long Term Debt and Total Stockholder Equity is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Long Term Debt of AtriCure are associated (or correlated) with its Total Stockholder Equity. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Stockholder Equity has no effect on the direction of Long Term Debt i.e., AtriCure's Long Term Debt and Total Stockholder Equity go up and down completely randomly.

Correlation Coefficient

0.93
Relationship DirectionPositive 
Relationship StrengthVery Strong

Long Term Debt

Long-term debt is a debt that AtriCure has held for over one year. Long-term debt appears on AtriCure balance sheet and also includes long-term leases. The most common forms of long term debt are bonds payable, long-term notes payable, mortgage payable, pension liabilities, and lease liabilities. In the corporate world, long-term debt is generally used to fund big-ticket items, such as machinery, buildings, and land. The total of long-term debt reported on AtriCure balance sheet is the sum of the balances of all categories of long-term debt. Debt that is not due within the current year and is often considered to be financing activities that are to be repaid over several years.

Total Stockholder Equity

The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders.
Most indicators from AtriCure's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into AtriCure current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AtriCure. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
For information on how to trade AtriCure Stock refer to our How to Trade AtriCure Stock guide.At present, AtriCure's Tax Provision is projected to increase significantly based on the last few years of reporting. The current year's Sales General And Administrative To Revenue is expected to grow to 0.78, whereas Enterprise Value Over EBITDA is projected to grow to (192.48).
 2021 2022 2023 2024 (projected)
Gross Profit205.9M245.9M300.4M315.4M
Total Revenue274.3M330.4M399.2M419.2M

AtriCure fundamental ratios Correlations

0.96-0.950.390.840.970.770.930.930.840.810.860.850.850.880.90.50.980.670.890.830.840.660.750.940.96
0.96-0.930.260.810.990.570.950.950.890.890.920.90.810.90.90.320.920.770.840.90.820.430.80.940.91
-0.95-0.93-0.27-0.87-0.97-0.71-0.94-0.95-0.88-0.83-0.89-0.86-0.89-0.91-0.92-0.43-0.92-0.71-0.84-0.89-0.89-0.56-0.79-0.93-0.94
0.390.26-0.270.250.260.570.10.1-0.040.060.080.050.250.030.070.380.33-0.120.66-0.060.230.63-0.060.460.29
0.840.81-0.870.250.830.710.770.770.680.580.650.630.990.760.780.510.840.450.70.680.990.520.510.740.8
0.970.99-0.970.260.830.620.970.970.910.890.930.910.840.920.920.350.930.770.850.920.850.480.820.950.94
0.770.57-0.710.570.710.620.580.560.410.330.430.410.720.540.60.780.810.180.70.390.70.970.330.640.76
0.930.95-0.940.10.770.970.581.00.950.920.960.950.790.930.930.290.90.820.760.960.80.440.880.90.92
0.930.95-0.950.10.770.970.561.00.970.930.970.970.780.930.920.240.880.820.760.970.80.40.90.910.9
0.840.89-0.88-0.040.680.910.410.950.970.940.980.980.690.930.910.090.80.880.620.980.720.260.950.810.81
0.810.89-0.830.060.580.890.330.920.930.940.980.970.590.870.84-0.040.730.910.70.970.630.20.950.870.77
0.860.92-0.890.080.650.930.430.960.970.980.980.990.660.910.890.10.80.910.720.980.690.30.960.890.84
0.850.9-0.860.050.630.910.410.950.970.980.970.990.640.90.880.050.790.880.680.970.680.280.960.860.81
0.850.81-0.890.250.990.840.720.790.780.690.590.660.640.790.810.50.840.450.720.690.990.530.530.760.81
0.880.9-0.910.030.760.920.540.930.930.930.870.910.90.791.00.270.870.790.650.930.80.40.890.810.87
0.90.9-0.920.070.780.920.60.930.920.910.840.890.880.811.00.340.90.750.670.910.810.470.860.810.89
0.50.32-0.430.380.510.350.780.290.240.09-0.040.10.050.50.270.340.59-0.060.40.090.460.79-0.020.310.6
0.980.92-0.920.330.840.930.810.90.880.80.730.80.790.840.870.90.590.610.790.780.830.710.690.860.95
0.670.77-0.71-0.120.450.770.180.820.820.880.910.910.880.450.790.75-0.060.610.480.920.490.070.880.70.69
0.890.84-0.840.660.70.850.70.760.760.620.70.720.680.720.650.670.40.790.480.640.720.620.570.960.82
0.830.9-0.89-0.060.680.920.390.960.970.980.970.980.970.690.930.910.090.780.920.640.720.230.950.830.83
0.840.82-0.890.230.990.850.70.80.80.720.630.690.680.990.80.810.460.830.490.720.720.510.580.770.81
0.660.43-0.560.630.520.480.970.440.40.260.20.30.280.530.40.470.790.710.070.620.230.510.220.530.66
0.750.8-0.79-0.060.510.820.330.880.90.950.950.960.960.530.890.86-0.020.690.880.570.950.580.220.770.74
0.940.94-0.930.460.740.950.640.90.910.810.870.890.860.760.810.810.310.860.70.960.830.770.530.770.89
0.960.91-0.940.290.80.940.760.920.90.810.770.840.810.810.870.890.60.950.690.820.830.810.660.740.89
Click cells to compare fundamentals

AtriCure Account Relationship Matchups

AtriCure fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets557.9M714.5M615.3M585.4M613.9M644.6M
Total Stockholder Equity247.3M412.4M483.8M456.8M466.2M489.5M
Retained Earnings(282.2M)(330.4M)(280.2M)(326.6M)(357.1M)(339.2M)
Other Assets705K16.5M955K2.0M1.00.95
Common Stock Shares Outstanding37.6M42.1M46.0M45.7M46.3M24.2M
Liabilities And Stockholders Equity557.9M714.5M615.3M585.4M613.9M644.6M
Other Stockholder Equity529.7M742.4M764.8M787.4M824.2M865.4M
Total Liab310.5M302.1M131.6M128.7M147.8M80.4M
Other Current Liab32.8M28.5M34.6M36.4M44.7M46.9M
Total Current Liabilities49.9M49.1M56.4M58.4M74.6M78.3M
Accounts Payable14.9M12.7M18.6M19.9M27.4M28.7M
Cash28.5M41.9M43.7M58.1M84.3M88.5M
Inventory29.4M35.0M39.0M45.9M67.9M71.3M
Other Current Assets3.9M4.3M5.0M5.5M8.6M9.0M
Common Stock40K45K46K47K48K28.1K
Property Plant Equipment32.6M28.3M36.2M42.6M49.0M51.5M
Property Plant And Equipment Net36.7M30.2M36.2M42.6M46.8M49.1M
Net Debt47.9M32.1M32.0M11.0M(9.8M)(9.3M)
Non Current Assets Total414.7M407.8M419.2M370.2M347.7M365.1M
Non Currrent Assets Other705K440K955K2.0M2.2M2.3M
Cash And Short Term Investments81.8M244.2M119.1M121.1M137.3M144.1M
Net Receivables28.0M23.1M33.0M42.7M52.5M55.1M
Common Stock Total Equity40K45K46K47K54.1K28.2K
Non Current Liabilities Total260.6M253.0M75.1M70.3M73.2M60.0M
Property Plant And Equipment Gross36.7M30.2M36.2M42.6M99.2M104.1M
Total Current Assets143.2M306.7M196.1M215.2M266.2M279.6M
Accumulated Other Comprehensive Income(158K)312K(948K)(4.1M)(993K)(943.4K)
Short Long Term Debt Total76.4M74.0M75.6M69.1M74.5M78.2M
Long Term Debt59.6M53.4M59.7M56.8M60.6M63.6M
Short Term Investments53.3M202.3M75.4M63.0M53.0M40.8M
Short Term Debt2.2M6.7M1.8M2.1M2.5M2.2M
Intangible Assets129.9M128.2M43.0M39.3M64.0M36.9M
Other Liab186.4M187.4M1.2M1.2M1.4M1.3M
Net Tangible Assets(117.3M)49.4M206.0M182.6M210.0M220.5M
Retained Earnings Total Equity(282.2M)(330.4M)(280.2M)(326.6M)(294.0M)(308.7M)
Long Term Debt Total59.6M53.4M59.7M56.8M65.4M34.9M
Capital Surpluse529.7M742.4M764.8M787.4M905.5M470.9M
Non Current Liabilities Other201.0M199.6M15.4M13.5M1.2M1.2M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether AtriCure offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of AtriCure's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Atricure Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Atricure Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AtriCure. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
For information on how to trade AtriCure Stock refer to our How to Trade AtriCure Stock guide.
You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of AtriCure. If investors know AtriCure will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about AtriCure listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.83)
Revenue Per Share
9.564
Quarterly Revenue Growth
0.179
Return On Assets
(0.04)
Return On Equity
(0.08)
The market value of AtriCure is measured differently than its book value, which is the value of AtriCure that is recorded on the company's balance sheet. Investors also form their own opinion of AtriCure's value that differs from its market value or its book value, called intrinsic value, which is AtriCure's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AtriCure's market value can be influenced by many factors that don't directly affect AtriCure's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between AtriCure's value and its price as these two are different measures arrived at by different means. Investors typically determine if AtriCure is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AtriCure's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.